These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37283687)

  • 1. Quantitative proteomic profiling of white matter in cases of cerebral amyloid angiopathy reveals upregulation of extracellular matrix proteins and clusterin.
    Manousopoulou A; Yuen HM; Sharp MM; Saito S; Aldea R; Mazer N; Garbis SD; Carare RO
    Free Neuropathol; 2020 Jan; 1():. PubMed ID: 37283687
    [No Abstract]   [Full Text] [Related]  

  • 2. Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy.
    Manousopoulou A; Gatherer M; Smith C; Nicoll JAR; Woelk CH; Johnson M; Kalaria R; Attems J; Garbis SD; Carare RO
    Neuropathol Appl Neurobiol; 2017 Oct; 43(6):492-504. PubMed ID: 27543695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
    Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
    Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy.
    Endo Y; Hasegawa K; Nomura R; Arishima H; Kikuta KI; Yamashita T; Inoue Y; Ueda M; Ando Y; Wilson MR; Hamano T; Nakamoto Y; Naiki H
    Acta Neuropathol Commun; 2019 Jan; 7(1):12. PubMed ID: 30691533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
    Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
    Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pattern of AQP4 Expression in the Ageing Human Brain and in Cerebral Amyloid Angiopathy.
    Owasil R; O'Neill R; Keable A; Nimmo J; MacGregor Sharp M; Kelly L; Saito S; Simpson JE; Weller RO; Smith C; Attems J; Wharton SB; Yuen HM; Carare RO
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic profiling in cerebral amyloid angiopathy reveals an overlap with CADASIL highlighting accumulation of HTRA1 and its substrates.
    Zellner A; Müller SA; Lindner B; Beaufort N; Rozemuller AJM; Arzberger T; Gassen NC; Lichtenthaler SF; Kuster B; Haffner C; Dichgans M
    Acta Neuropathol Commun; 2022 Jan; 10(1):6. PubMed ID: 35074002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways.
    Wojtas AM; Kang SS; Olley BM; Gatherer M; Shinohara M; Lozano PA; Liu CC; Kurti A; Baker KE; Dickson DW; Yue M; Petrucelli L; Bu G; Carare RO; Fryer JD
    Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6962-E6971. PubMed ID: 28701379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of perivascular drainage of β-amyloid in cerebral amyloid angiopathy.
    Hawkes CA; Jayakody N; Johnston DA; Bechmann I; Carare RO
    Brain Pathol; 2014 Jul; 24(4):396-403. PubMed ID: 24946077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: sporadic cerebral amyloid angiopathy.
    Attems J; Jellinger K; Thal DR; Van Nostrand W
    Neuropathol Appl Neurobiol; 2011 Feb; 37(1):75-93. PubMed ID: 20946241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases.
    Craggs L; Taylor J; Slade JY; Chen A; Hagel C; Kuhlenbaeumer G; Borjesson-Hanson A; Viitanen M; Kalimo H; Deramecourt V; Oakley AE; Kalaria RN
    Neuropathol Appl Neurobiol; 2016 Feb; 42(2):194-209. PubMed ID: 25940137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease.
    Roher AE; Kuo YM; Esh C; Knebel C; Weiss N; Kalback W; Luehrs DC; Childress JL; Beach TG; Weller RO; Kokjohn TA
    Mol Med; 2003; 9(3-4):112-22. PubMed ID: 12865947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter changes in dementia: role of impaired drainage of interstitial fluid.
    Weller RO; Hawkes CA; Kalaria RN; Werring DJ; Carare RO
    Brain Pathol; 2015 Jan; 25(1):63-78. PubMed ID: 25521178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy.
    Keable A; Fenna K; Yuen HM; Johnston DA; Smyth NR; Smith C; Al-Shahi Salman R; Samarasekera N; Nicoll JA; Attems J; Kalaria RN; Weller RO; Carare RO
    Biochim Biophys Acta; 2016 May; 1862(5):1037-46. PubMed ID: 26327684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
    Jang H; Jang YK; Kim HJ; Werring DJ; Lee JS; Choe YS; Park S; Lee J; Kim KW; Kim Y; Cho SH; Kim SE; Kim SJ; Charidimou A; Na DL; Seo SW
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1287-1298. PubMed ID: 30937462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of candidate genetic variants and circulating levels of ApoE/ApoJ with common neuroimaging features of cerebral amyloid angiopathy.
    Bonaterra-Pastra A; Benítez S; Pancorbo O; Rodríguez-Luna D; Vert C; Rovira A; Freijo MM; Tur S; Martínez-Zabaleta M; Cardona Portela P; Vera R; Lebrato-Hernández L; Arenillas JF; Pérez-Sánchez S; Domínguez-Mayoral A; Fàbregas JM; Mauri G; Montaner J; Sánchez-Quesada JL; Hernández-Guillamon M
    Front Aging Neurosci; 2023; 15():1134399. PubMed ID: 37113571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy.
    Camacho J; Moliné T; Bonaterra-Pastra A; Ramón Y Cajal S; Martínez-Sáez E; Hernández-Guillamon M
    Front Neurol; 2019; 10():187. PubMed ID: 30918495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of White Matter Abnormalities in the Relationship Between Microbleed Burden and Cognitive Impairment in Cerebral Amyloid Angiopathy.
    Jo S; Cheong EN; Kim N; Oh JS; Shim WH; Kim HJ; Lee SJ; Lee Y; Oh M; Kim JS; Kim BJ; Roh JH; Kim SJ; Lee JH
    J Alzheimers Dis; 2022; 86(2):667-678. PubMed ID: 35124637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sushi repeat-containing protein 1: a novel disease-associated molecule in cerebral amyloid angiopathy.
    Inoue Y; Ueda M; Tasaki M; Takeshima A; Nagatoshi A; Masuda T; Misumi Y; Kosaka T; Nomura T; Mizukami M; Matsumoto S; Yamashita T; Takahashi H; Kakita A; Ando Y
    Acta Neuropathol; 2017 Oct; 134(4):605-617. PubMed ID: 28478503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort.
    Costa AS; Pinho J; Kučikienė D; Reich A; Schulz JB; Reetz K
    J Alzheimers Dis; 2021; 79(4):1661-1672. PubMed ID: 33492291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.